PPARG locus haplotype variation and exacerbations in asthma

Clin Pharmacol Ther. 2007 May;81(5):713-8. doi: 10.1038/sj.clpt.6100119. Epub 2007 Feb 28.

Abstract

The peroxisome proliferator-activated receptor gamma (PPARgamma) regulates inflammation and may play a role in asthma. Using mouthwash-derived DNA and clinical interviews and measurements, we investigated the association of previously characterized single-nucleotide polymorphisms in the PPARG gene (Pro12Ala, C1431T, and C-681G) with asthma exacerbations in patients aged 3-22 years (n=569). The common homozygous haplotype combination of the Pro12 and C1431 alleles was associated with increased risk for asthma exacerbations (ProC, odds ratio (OR) 1.87, 95% confidence interval 1.25-2.79; P=0.002). The ProC genotype was associated with increased school absences (OR 1.82, 95% confidence interval 1.21-2.76; P=0.004) and hospital admissions (OR 2.32, 95% confidence interval 1.18-4.58; P=0.015) over the preceding 6 months. The population-attributable risk of this genotype was 33%. Common genetic variation at the PPARG locus may play an important role in modulating the long-term control of asthma in children and young adults.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Alleles
  • Asthma / epidemiology
  • Asthma / genetics*
  • Asthma / physiopathology*
  • Child
  • Child, Preschool
  • Confidence Intervals
  • DNA / genetics
  • Female
  • Genotype
  • Haplotypes
  • Hospitalization / statistics & numerical data
  • Humans
  • Linkage Disequilibrium / genetics
  • Male
  • Odds Ratio
  • PPAR gamma / genetics*
  • Risk Assessment
  • United Kingdom / epidemiology

Substances

  • PPAR gamma
  • DNA